Global Schistosomiasis Alliance

@gsa.bsky.social

The Global Schistosomiasis Alliance (GSA) is the network facilitating collaboration, coordination and knowledge exchange for the control and elimination of schistosomiasis. The GSA network and platform is funded by Merck (Merck KGaA)

We encourage you to read this compelling The New York Times story. It explores the road ahead for NTD elimination efforts following global shifts, and the innovative ways that countries are integrating treatment campaigns to continue driving the work forward.

The Task Force for Global Health@taskforce.bsky.social · 6mo ago

This powerful @nytimes.com story by @stephanienolen.bsky.social features @taskforce.bsky.social Director Dr. Pat Lammie's perspective on the future of NTD elimination. Read why partnerships and sustained investment are critical to preserving the gains we've made. #beatNTDs nyti.ms/4tvF4TE

Lookin at a pragmatic path from research to practice in treating PSAC for schistosomiasis, today's @isntd.org Connect unpacks findings from a landmark trial in Uganda comparing PZQ dosing regimens, and discuss the urgent need & practical steps to include this age group in treatment strategies.

Global Schistosomiasis Alliance@gsa.bsky.social · 8mo ago

Today's @isntd.org webinar focuses on the off-label treatment” use of standard praziquantel to treat under 5yr olds. New study shows dosage & safety for 40 mg/kg vs. 80 mg/kg. 📄 thelancet.com/journals/lan...